{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T19:31:05Z","timestamp":1772739065419,"version":"3.50.1"},"reference-count":32,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"First Hospital of Jilin University","award":["JDYYJC006"],"award-info":[{"award-number":["JDYYJC006"]}]},{"name":"Tianqing Liver Disease Research Fund","award":["TQGB20180160"],"award-info":[{"award-number":["TQGB20180160"]}]},{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"crossref","award":["20180520116JH"],"award-info":[{"award-number":["20180520116JH"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background &amp; Aims<\/jats:title>\n                    <jats:p>Factors that influence the outcomes after deceased-donor liver transplantation (DDLT) for primary biliary cirrhosis (PBC) are not well known. We aimed to clarify these effects on the outcomes after DDLT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed patients with PBC who underwent DDLT from March 2006 to July 2018 at the organ transplantation center of the First Hospital of Jilin University and the First Central Hospital of Tianjin. Changes in liver function were assessed posttransplantation. Recurrence, survival rate, and complications were recorded at follow-up. The effect of liver transplantation on survival and recurrence was evaluated using univariate and\/or multivariate Cox regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 69 patients with PBC undergoing DDLT were included in this study. At 4 weeks posttransplant, all liver function tests were normal. During a median follow-up time of 32 months, 5-year overall survival and recurrence rates were estimated as 95.1% and 21.8%, respectively. A recipient aspartate aminotransferase-to-platelet ratio index (APRI) greater than 2 was negatively associated with survival (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.0018). Multivariate regression analysis demonstrated that age younger than 48 years was an independent risk factor for recurrent PBC in recipients undergoing liver transplantation (hazard ratio 0.028, 95% confidence interval 0.01\u20130.71,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.03). Posttransplant infections (62%) and biliary tract complications (26%) were the most common complications.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Liver transplantation is an effective treatment for patients with PBC. Liver function normalizes by 4 weeks posttransplant. Although posttransplant survival rate is high, recurrence is possible. To some extent, survival rate and recurrence rate can be predicted by APRI and age, respectively.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.7717\/peerj.9563","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T05:30:27Z","timestamp":1597815027000},"page":"e9563","source":"Crossref","is-referenced-by-count":3,"title":["The long-term outcomes of deceased-donor liver transplantation for primary biliary cirrhosis: a two-center study in China"],"prefix":"10.7717","volume":"8","author":[{"given":"Lin","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Hepatology, First Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, First Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoyue","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic Surgery, First Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic Surgery, First Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Transplant Center, First Central Hospital, Tianjin, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjun","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Hepatology, First Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqi","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Hepatology, First Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinglan","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Hepatology, First Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatology, First Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4443","published-online":{"date-parts":[[2020,8,19]]},"reference":[{"key":"10.7717\/peerj.9563\/ref-1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)","volume":"57","author":"Adam","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.7717\/peerj.9563\/ref-2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.5582\/irdr.2012.v1.2.66","article-title":"Primary biliary cirrhosis and liver transplantation","volume":"1","author":"Akamatsu","year":"2012","journal-title":"Intractable & Rare Diseases Research"},{"key":"10.7717\/peerj.9563\/ref-3","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/lt.24217","article-title":"Serum fibrosis biomarkers predict death and graft loss in liver transplantation recipients","volume":"21","author":"Bhat","year":"2015","journal-title":"Liver Transplantation"},{"key":"10.7717\/peerj.9563\/ref-4","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.jhep.2015.07.038","article-title":"Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence","volume":"63","author":"Bosch","year":"2015","journal-title":"Journal of Hepatology"},{"key":"10.7717\/peerj.9563\/ref-5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cld.2012.12.005","article-title":"Liver transplant for cholestatic liver diseases","volume":"17","author":"Carrion","year":"2013","journal-title":"Clinics in Liver Disease"},{"key":"10.7717\/peerj.9563\/ref-6","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transplantation"},{"key":"10.7717\/peerj.9563\/ref-7","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/S0041-1345(00)01642-0","article-title":"Primary graft dysfunction after liver transplantation","volume":"32","author":"Chui","year":"2000","journal-title":"Transplantation Proceedings"},{"key":"10.7717\/peerj.9563\/ref-8","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/hep.510310337","article-title":"Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An international panel","volume":"31","author":"Demetris","year":"2000","journal-title":"Hepatology"},{"key":"10.7717\/peerj.9563\/ref-9","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/0168-8278(95)80033-6","article-title":"Kinetics of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis","volume":"23","author":"Dubel","year":"1995","journal-title":"Journal of Hepatology"},{"key":"10.7717\/peerj.9563\/ref-10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"EASL","year":"2017","journal-title":"Journal of Hepatology"},{"key":"10.7717\/peerj.9563\/ref-11","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/ajt.13583","article-title":"Long-term outcomes of living-donor liver transplantation for primary biliary cirrhosis: a Japanese multicenter study","volume":"16","author":"Egawa","year":"2016","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 3","key":"10.7717\/peerj.9563\/ref-12","doi-asserted-by":"publisher","first-page":"S463","DOI":"10.1111\/j.1872-034X.2007.00245.x","article-title":"Histological recurrence of autoimmune liver diseases after living-donor liver transplantation","volume":"37","author":"Haga","year":"2007","journal-title":"Hepatology Research"},{"key":"10.7717\/peerj.9563\/ref-13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"American Journal of Infection Control"},{"key":"10.7717\/peerj.9563\/ref-14","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1007\/s11605-010-1256-1","article-title":"Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases\u2013an analysis of the UNOS database","volume":"14","author":"Kashyap","year":"2010","journal-title":"Journal of Gastrointestinal Surgery"},{"key":"10.7717\/peerj.9563\/ref-15","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.transproceed.2010.02.037","article-title":"Vascular complications after deceased and living donor liver transplantation: a single-center experience","volume":"42","author":"Khalaf","year":"2010","journal-title":"Transplantation Proceedings"},{"key":"10.7717\/peerj.9563\/ref-16","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1016\/j.transproceed.2009.07.003","article-title":"Role of postreperfusion subcapsular wedge biopsies in predicting initially poor graft function after liver transplantation","volume":"41","author":"Kocbiyik","year":"2009","journal-title":"Transplantation Proceedings"},{"key":"10.7717\/peerj.9563\/ref-17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1055\/s-2005-916323","article-title":"The natural history of PBC: has it changed?","volume":"25","author":"Lee","year":"2005","journal-title":"Seminars in Liver Disease"},{"key":"10.7717\/peerj.9563\/ref-18","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.3748\/wjg.v18.i16.1975","article-title":"Analysis of infections in the first 3-month after living donor liver transplantation","volume":"18","author":"Li","year":"2012","journal-title":"World Journal of Gastroenterology"},{"key":"10.7717\/peerj.9563\/ref-19","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/lt.23704","article-title":"Liver transplantation and autoimmune liver diseases","volume":"19","author":"Liberal","year":"2013","journal-title":"Liver Transplantation"},{"key":"10.7717\/peerj.9563\/ref-20","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1056\/NEJMct074694","article-title":"Ursodeoxycholic acid for the treatment of primary biliary cirrhosis","volume":"357","author":"Lindor","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.7717\/peerj.9563\/ref-21","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3748\/wjg.v22.i4.1617","article-title":"Vascular complications after adult living donor liver transplantation: evaluation with ultrasonography","volume":"22","author":"Ma","year":"2016","journal-title":"World Journal of Gastroenterology"},{"key":"10.7717\/peerj.9563\/ref-22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.transproceed.2016.02.033","article-title":"Biliary complications after liver transplantation: incidence. Risk factors and impact on patient and graft survival","volume":"48","author":"Mejia","year":"2016","journal-title":"Transplantation Proceedings"},{"key":"10.7717\/peerj.9563\/ref-23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/hep.1840200120","article-title":"Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits","volume":"20","author":"Murtaugh","year":"1994","journal-title":"Hepatology"},{"key":"10.7717\/peerj.9563\/ref-24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12291-012-0245-4","article-title":"A single centre prospective study of liver function tests in post liver transplant patients","volume":"28","author":"Naik","year":"2013","journal-title":"Indian Journal of Clinical Biochemistry"},{"key":"10.7717\/peerj.9563\/ref-25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/nejm198201073060101","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation","volume":"306","author":"Neuberger","year":"1982","journal-title":"New England Journal of Medicine"},{"key":"10.7717\/peerj.9563\/ref-26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000431017","article-title":"Liver transplantation for patients with cholestatic liver diseases","volume":"31","author":"Schoning","year":"2015","journal-title":"Viszeralmedizin"},{"key":"10.7717\/peerj.9563\/ref-27","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/s0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis","volume":"377","author":"Selmi","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.7717\/peerj.9563\/ref-28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/s2468-1253(19)30343-7","article-title":"Current and potential treatments for primary biliary cholangitis","volume":"5","author":"Shah","year":"2019","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"10.7717\/peerj.9563\/ref-29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1399-0012.2010.01288.x","article-title":"Liver transplantation for primary biliary cirrhosis in a hepatitis endemic region: a single-center Asian experience","volume":"25","author":"Sun","year":"2011","journal-title":"Clinical Transplantation"},{"key":"10.7717\/peerj.9563\/ref-30","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/j.1399-3062.2011.00640.x","article-title":"Incidence and risk factors for infections after liver transplant: single-center experience at the University Hospital Fundacion Santa Fe de Bogota, Colombia","volume":"130","author":"Vera","year":"2011","journal-title":"Transplant Infectious Disease"},{"key":"10.7717\/peerj.9563\/ref-31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000144653","article-title":"Biliary tract complications after liver transplantation: a review","volume":"25","author":"Wojcicki","year":"2008","journal-title":"Digestive Surgery"},{"key":"10.7717\/peerj.9563\/ref-32","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.transproceed.2006.11.021","article-title":"Role of reactive oxygen species in mediating hepatic ischemia-reperfusion injury and its therapeutic applications in liver transplantation","volume":"39","author":"Zhang","year":"2007","journal-title":"Transplantation Proceedings"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/9563.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/9563.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/9563.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/9563.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T05:30:36Z","timestamp":1597815036000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/9563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,19]]},"references-count":32,"alternative-id":["10.7717\/peerj.9563"],"URL":"https:\/\/doi.org\/10.7717\/peerj.9563","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.7287\/peerj.9563v0.1\/reviews\/2","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.9563v0.2\/reviews\/1","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.9563v0.2\/reviews\/2","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.9563v0.1\/reviews\/1","asserted-by":"object"}]},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,19]]},"article-number":"e9563"}}